Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells

Cancer Letters

Volumn 215, Issue 2, 2004, Pages 159-166

  Yu, Zengli ^a   Li, Wenjie ^a   Liu, Fuyun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; Genistein; HT 29 cell

Indexed keywords

GENISTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRAIN HT29; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; GENE CONTROL; HUMAN; HUMAN CELL; MOLECULE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G2 PHASE; GENES, BCL-2; GENISTEIN; HT29 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 5644227426     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.010     Document Type: Article

References (50)

1. P. Pisani, D.M. Parkin, and J. Ferlay Estimates of the worldwide mortality from eighteen major cancers in 1985 Int. J. Cancer 54 1993 594 606
2. M. Messina, and S. Barnes The role of soy products in reducing risk of cancer J. Natl Cancer Inst. 83 1991 541 546
3. B.K. Jacobsen, S.F. Knutsen, and G.E. Fraser Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States) Cancer Causes Control 6 1998 553 557
4. S. Barnes Effect of genistein on in vitro and in vivo models of cancer J. Nutr. 125 1995 777S 783S
5. H. Wei, R. Bowen, Q. Cai, S. Barnes, and Y. Wang Antioxidant and anti-promotion effects of the soybean isoflavone genistein Proc. Soc. Exp. Biol. Med. 208 1995 124 130
6. S. Barnes Effect of genistein on in vitro and in vivo models of cancer J. Nutr. 125 1995 777S 783S
7. D.C. Knight, and J.A. Eden A review of the clinical effects of phytoestrogens Obstet. Gynecol. 87 1996 897 904
8. K.D. Setchell Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones Am. J. Clin. Nutr. 68 1998 1333S 1346S
9. Q. Zhu, J. Meisinger, D.H. Van Thiel, Y. Zhang, and S. Mobarhan Effects of soybean extract on morphology and survival of Caco-2, SW620, and HT-29 cells Nutr. Cancer 42 2002 131 140
10. Z.M. Shao, M.L. Alpaugh, J.A. Fontana, and S.H. Barsky Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis J. Cell Biochem. 69 1998 44 54
11. S.J. Su, T.M. Yeh, H.Y. Lei, and N.H. Chow The potential of soybean foods as a chemoprevention approach for human urinary tract cancer Clin. Cancer Res. 6 2000 230 236
12. Y. Matsukawa, N. Marui, T. Sakai, Y. Satomi, M. Yoshida, and K. Matsumoto Genistein arrests cell cycle progression at G2-M Cancer Res 53 1993 1328 1331
13. Y.H. Choi, L. Zhang, W.H. Lee, and K. Park Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells Int. J. Oncol. 13 1998 391 396
14. J.N. Davis, B. Singh, M. Bhuiyan, and F.H. Sarkar Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells Nutr. Cancer 32 1998 123 131
15. (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells J. Cancer Res. 91 2000 164 173
16. F. Lian, M. Bhuiyan, Y. Li, N. Wall, M. Kraut, and F.H. Sarkar Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line Nutr. Cancer 31 1998 184 191
17. T. Kuzumaki, T. Kobayashi, and K. Ishikawa Genistein induces p21Cip1/WAF1 expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells Biochem. Biophys. Res. Commun. 251 1998 291 295
18. J.Y. Guo, X. Li, J.D. Browning, G.E. Rottinghaus, D.B. Lubahn, and A. Constantinou Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer J. Nutr. 134 2004 179 182
19. D.E. Fisher Apoptosis in cancer therapy: crossing the threshold Cell 78 1994 539 542
20. C.J. Sherr Mammalian G1 cyclins Cell 73 1993 1059 1065
21. T. Hunter Braking the cycle Cell 75 1993 839 841
22. J. Kato, H. Matsushime, S.W. Hiebert, M.E. Ewen, and C.J. Sherr Direct binding of cyclin D to the retinoblastoma gene product and pRb phosphorylation by the cyclin D-dependent kinase cdk4 Genes Dev. 7 1993 331 342
23. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach p21 is a universal inhibitor of cyclin kinases Nature 366 1993 701 704
24. S.J. Bhathena, and M.T. Velasquez Beneficial role of dietary phytoestrogens in obesity and diabetes Am. J. Clin. Nutr. 76 2002 1191 1201
25. American Cancer Society Cancer Facts and Figures 1993 American Cancer Society Atlanta, GA
26. S. Goldwyn, A. Lazinsky, and H. Wei Promotion of health by soy isoflavones: efficacy, benefit and safety concerns Drug Metabol. Drug Interact. 17 2000 261 289
27. K.L. Chang, M.L. Kung, N.H. Chow, and S.J. Su Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1 Biochem. Pharmacol. 67 2004 717 726
28. W.F. Chen, M.H. Huang, C.H. Tzang, M. Yang, and M.S. Wong Inhibitory actions of genistein in human breast cancer (MCF-7) cells Biochim. Biophys. Acta 1638 2003 187 196
29. A.L. Hewitt, and K.W. Singletary Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model Cancer Lett. 192 2003 133 143
30. D.G. Thiagarajan, M.R. Bennink, L.D. Bourquin, and F.A. Kavas Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium Am. J. Clin. Nutr. 68 1998 1394S 1399S
31. M. Messina, and M. Bennink Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data Baillieres Clin. Endocrinol. Metab. 12 1998 707 728
32. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach p21 is a universal inhibitor of cyclin kinases Nature. 366 1993 701 704
33. Y. Li, C.W. Jenkins, M.A. Nichols, and Y. Xiong Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21 Oncogene 9 1994 2261 2268
34. J.C. Reed Bcl-2 family proteins Oncogene 17 1998 3225 3236
35. A. Gross, J.M. McDonnell, and S. Korsmeyer Bcl-2 family members and the mitochondria in apoptosis Genes Dev. 13 1999 1899 1911
36. Z.N. Oltvai, C.L. Millman, and S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death Cell 74 1993 609 619
37. Y.H. Choi, K.R. Kong, Y.A. Kim, K.O. Jung, J.H. Kil, S.H. Rhee, and K.Y. Park Induction of Bax and activation of caspases during beta-sitosterol-mediated apoptosis in human colon cancer cells Int. J. Oncol. 23 2003 1657 1662
38. E. Whitte Life, death, the pursuit of apoptosis Genes Dev. 10 1996 1 15
39. P. Levy, H. Robin, F. Bertrand, M. Kornprobst, and J. Capeau Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation J. Cell Physiol. 197 2003 336 347
40. N. Arai, A. Strom, J.J. Rafter, and J.A. Gustafsson Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein Biochem. Biophys. Res. Commun. 270 2000 425 431
41. C.W. Hendrickse, C.E. Jones, I.A. Donovan, J.P. Neoptolemos, and P.R. Baker Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines Br. J. Surg. 80 1993 636 640
42. G.G.J.M. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, and P.T. Saag Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology 139 1998 4252 4263
43. A.C. Pike, A.M. Brzozowski, R.E. Hubbard, T. Bonn, A.G. Thorsell, and O. Engstrom Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist Eur. Mol. Biol. Org. J. 18 1999 4608 4618
44. C.D. Allred, K.F. Allred, Y.H. Ju, S.M. Virant, and W.G. Helferich Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dosedependent manner Cancer Res. 61 2001 5045 5050
45. C.V. Rao, C.X. Wang, B. Simi, R. Lubet, G. Kelloff, V. Steele, and B.S. Reddy Enhancement of experimental colon cancer by genistein Cancer Res. 57 1997 3717 3722
46. D.F. McMichael-Phillips, C. Harding, M. Morton, S.A. Roberts, A. Howell, C.S. Potten, and N.J. Bundred Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast Am. J. Clin. Nutr. 68 suppl. 6 1998 1431S 1435S
47. S.M. Kuo, H.F. Morehouse Jr., and C.P. Lin Effect of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells Cancer Lett. 116 1997 131 137
48. C.Y. Hsieh, R.C. Santell, S.Z. Haslam, and W.G. Helferich Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res. 58 1998 3833 3838
49. A. Cassidy Potential tissue selectivity of dietary phytoestrogens and estrogens Curr. Opin. Lipidol. 10 1999 47 52
50. D.S. Michaud, D. Spiegelman, S.K. Clinton, E.B. Rimm, W.C. Willett, and E.L. Giovannucci Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort J. Natl Cancer Inst. 91 1999 605 613